Update On The Availability Of Xeomin
By Brenna Fisher , Contributing Writer |
Used to treat frown lines between the eyebrows, Xeomin, which is the only FDA-approved botulinum toxin that does not require refrigeration, may have a brief interruption in availability due to an injunction against Merz, its manufacturer. The result of a lawsuit disputing Merz's use of commercial trade secrets, the injunction has placed some limitations on sales of Xeomin for 10 months, a time frame which may be reduced or terminated if the company satisfies the examination and remediation process. To clear up any confusion, this doesn't mean there is anything wrong with the actual product.
In a recent release, the CEO of Merz, Inc., William D. Humphries said, “We regret that this ruling will affect physicians and patients as we believe that access to quality FDA approved treatment options, including Xeomin (incobotulinumtoxinA), is a cornerstone of the U.S. market. It is critical at this juncture to clarify that this lawsuit, which is commercial in nature and focuses specifically on alleged trade secrets, did not call into question the quality of Xeomin.”
What does it mean to you? Physicians who already have the product can continue to use it. So you'll likely be able to get the product at your current doctor's office, but you may want to inquire in advance.
The Wrinkle Relaxer Roundup